Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human Tumor Antigens Yesterday, Today, and Tomorrow

1 May 2017

Abstract excerpt

Abstract The question of whether human tumors express antigens that can be recognized by the immune system has been answered with a resounding YES. Most were identified through spontaneous antitumor humoral and cellular immune responses found in cancer patients and include peptides, glycopeptides, phosphopeptides, viral peptides, and peptides resulting from common mutations in oncogenes and tumor-suppressor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immunotherapy and Immune Responses
Share to vaccines and immunoinformatics approaches

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28465452
DOI: 10.1158/2326-6066.cir-17-0112

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human Tumor Antigens Yesterday, Today, and TomorrowPMID 28465452Read ↗

Unique Human Tumor Antigens: Immunobiology and Use in Clinical TrialsSemantic proximity Read ↗

Identification of human tumor antigens and its implications for diagnosis and treatment of cancerSemantic proximity Read ↗

Human tumor antigens are ready to fly.Semantic proximity Read ↗

The repertoire of human tumor-associated epitopes — identification and selection of antigens and their application in clinical trialsSemantic proximity Read ↗

Tumor Antigens beyond the Human Exome.Semantic proximity Read ↗

Tumor neoantigens: building a framework for personalized cancer immunotherapy.Semantic proximity Read ↗

Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer.Semantic proximity Read ↗

Targeting Driver Oncogenes and Other Public Neoantigens Using T Cell Receptor–Based Cellular TherapySemantic proximity Read ↗

Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies.Semantic proximity Read ↗

Identification and Targeting of Mutant Peptide Neoantigens in Cancer ImmunotherapySemantic proximity Read ↗

Progress in Neoantigen Targeted Cancer ImmunotherapiesSemantic proximity Read ↗

Proteogenomic analysis unveils the HLA Class I presented immunopeptidome in melanoma and EGFR mutant lung adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.